USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ALZCHEM AG

USPTO PatentsView assignee record — 15 granted patents across 17 technology areas, active 2016–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS).

15
Total patents granted
17
CPC technology areas
21.4
Avg claims per patent
-93%
5-year filing velocity

Portfolio overview

ALZCHEM AG has been granted 15 US utility patents between 2016 and 2020, placing ALZCHEM AG at rank #18,350 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). As a Foreign Corporation, ALZCHEM AG is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 37.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 14 in the 2015–2019 window — a -93% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ALZCHEM AG's 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ALZCHEM AG against peers pursuing similar technology classes.

How does ALZCHEM compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows ALZCHEM holds 15 patents — placing it at rank #18,350 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2016–2020

0246810 2016201720182020 1
USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
ALZCHEM AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 9 60.0%
2017 4 26.7%
2018 1 6.7%
2020 1 6.7%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#18,350

Across all tracked assignees

Innovation Score

37.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ALZCHEM AG hold?
ALZCHEM AG holds 15 US granted patents filed between 2016 and 2020, spanning 17 technology areas.
What is ALZCHEM AG's Innovation Score?
ALZCHEM AG has an Innovation Score of 37.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ALZCHEM AG focus on?
ALZCHEM AG's top technology area is C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS) with 10 patents. The company has filed patents in 17 CPC subclasses total.
Is ALZCHEM AG's patent filing rate increasing or decreasing?
ALZCHEM AG's recent filing velocity is -93% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for ALZCHEM AG's patents?
ALZCHEM AG's patents average 21.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the ALZCHEM AG patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope